Detection and follow-up of chronic obstructive pulmonary disease (COPD) and risk factors in the Southern Cone of Latin America. The pulmonary risk in South America (PRISA) study

BMC Pulmonary Medicine

Volumn 11, Issue , 2011, Pages

  Rubinstein, Adolfo L ^a   Irazola, Vilma E ^a   Bazzano, Lydia A ^b   Sobrino, Edgardo ^a   Calandrelli, Matías ^c   Lanas, Fernando ^d   Lee, Alison G ^e   Manfredi, Jose A ^f   Olivera, Héctor ^g   Ponzo, Jacqueline ^f   Seron, Pamela ^d   He, Jiang ^b  

^a Centro de Excelencia en Salud Cardiovascular Para El Cono sur CESCAS Instituto de Efectividad Clínica y Sanitaria   (Argentina)

^b TULANE UNIVERSITY   (United States)

^c Sanatorio San Carlos   (Argentina)

^d UNIVERSIDAD DE LA FRONTERA   (Chile)

^e Centro de Excelencia en Salud Cardiovascular para el Cono Sur   (Argentina)

^f UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^g Municipalidad de Marcos Paz   (Argentina)

Author keywords

Chronic Obstructive Pulmonary DiseaseRisk FactorsSouth America; Cohort

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HUMAN; INCIDENCE; MALE; OUTCOME ASSESSMENT; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SMOKING; SOCIAL STATUS; SOUTH AND CENTRAL AMERICA; SPIROMETRY; ARGENTINA; CHILE; COHORT ANALYSIS; LONGITUDINAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SOCIAL CLASS; SOUTH AMERICA; URUGUAY;

AGED; ARGENTINA; CHILE; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SOCIAL CLASS; SOUTH AMERICA; SPIROMETRY; URUGUAY;

EID: 79957650186     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-11-34     Document Type: Article

References (30)

1. Committee G. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2009, Medical Communications Resources, Inc.
2. Mary Ellen Wewers WCB, Kai-Hakin C, Mark ED, Patricia F, Janie H, Mary KD, Tom K, Grace PW, Virginia RC, Arunabh T, Katherine T. An Official American Thoracic Society Workshop Report: Tobacco Control Initiatives within the American Thoracic Society. Proc Am Thorac Soc 2010, 7:1-7. 10.1513/pats.200811-120ST, 20160142.
3. Organization WH World Health Statistics 2008. 2008, 110. Organization WH.
4. Halbert RJ NJ, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006, 28:523-532. 10.1183/09031936.06.00124605, 16611654.
5. Miravitlles M, Murio C, Tirado-Conde G, Levy G, Muellerova H, Soriano JB, Ramirez-Venegas A, Ko FW, Canelos-Estrella B, Giugno E, et al. Geographic differences in clinical characteristics and management of COPD: the EPOCA study. Int J Chron Obstruct Pulmon Dis 2008, 3:803-814. 2650616, 19281096.
6. Hnizdo GHE, Petsonk E, Buist A. Case definitions for Chronic Obstructive Pulmonary Disease. J COPD 2006, 3:1-6.
7. Wilt TJ ND, Kim C, Kane RL, Linabery A, Tacklind J, Macdonald R, Rutks I. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). Evid Rep Technol Assess (summ) 2005, 121:1-7.
8. Menezes AM, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Hallal PC, Victora CG. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005, 366:1875-1881. 10.1016/S0140-6736(05)67632-5, 16310554.
9. Sáenz CB SM, Blaho E, et al. Costos en enfermedad pulmonar obstructiva crónica. Revista Argentina de Medicina Respiratoria 2001, 1:45-51.
10. Champagne BM, Sebrie EM, Schargrodsky H, Pramparo P, Boissonnet C, Wilson E. Tobacco smoking in seven Latin American cities: the CARMELA study. Tob Control 19:457-462.
11. Muller F, Wehbe L. Smoking and smoking cessation in Latin America: a review of the current situation and available treatments. Int J Chron Obstruct Pulmon Dis 2008, 3:285-293. 2629971, 18686737.
12. Taha A, Ball K. Tobacco and the Third World: the growing threat. East Afr Med J 1985, 62:735-741.
13. L SA. Diseño Razonado De Muestras Y Captación De Datos Para La Investigación Sanitaria 2000,
14. Lemeshow LP. Sampling of Populations: Methods and Applications 1999,
15. Campaign for Tobacco-fee Kids: International Resource Center. , http://www.tobaccofreecenter.org
16. Usual Dietary Intakes: NHANES Food Frequency Questionnaire (FFQ). , http://riskfactor.cancer.gov/diet/usualintakes/ffq.html
17. Kroenke SRK, Williams JB. The PHQ-9: Validity of a Brief Depression Severity Measure. J Gen Intern Med 2001, 16:606-613. 10.1046/j.1525-1497.2001.016009606.x, 1495268, 11556941.
18. S B. Screening of mental disorders in primary care: linguistic adaptation procedure of a diagnostic instrument. Acta psiquiátr psicol Am Lat 1999, 45:223-234.
19. The Hispanic Community Health Study/Study of Latinos. , http://www.cscc.unc.edu/hchs/
20. International Physical Activity Questionnaire. , http://www.ipaq.ki.se/ipaq.htm
21. The SF-12: An Even Shorter Health Survey. , http://www.sf-36.org/tools/sf12.shtml
22. European Quality of Life 5-Dimensions. , http://www.euroqol.org/
23. Augustovski FA IV, Velazquez AP, Gibbons L, Craig BM. Argentine valuation of the EQ-5D health states. Value Health 2009, 12:587-596. 10.1111/j.1524-4733.2008.00468.x, 19900257.
24. Augustovski FA LG, Elorrio EG, Rubinstein A. The Argentine-Spanish SF-36 Health Survey was successfully validated for local outcome research. J Clin Epidemiol 2008, 61:1279-1284. 10.1016/j.jclinepi.2008.05.004, 18786809.
25. Hosmer D, Lemeshow S. Applied logistic regression 2000, 2.
26. Kleinbaum D, Kupper LN, A Muller K. Applied Regression Analysis and Multivariable Methods 2007, Duxbury Applied, 3.
27. Hosmer D, May S. Applied Survival Analysis: Regression Modeling of Time to Event Data 2008, 2.
28. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946. 10.1183/09031936.04.00014304, 15219010.
29. Laszlo G. Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax 2006, 61:744-746. 10.1136/thx.2006.061648, 2117098, 16936234.
30. Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:1-100.